|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for US Patent 12,514,898
What is the scope of US Patent 12,514,898?
US Patent 12,514,898 covers a method of treating a specific condition with a novel compound or composition. The patent's claims focus on the chemical structure, dosage, and administration protocol of the drug. It aims to secure exclusive rights to a new molecular entity or its use in a targeted therapy.
Patent Claims Breakdown
- Claim 1: Defines the core compound, specifying the molecular formula and stereochemistry.
- Claim 2: Details the administration method, including dosage range, frequency, and delivery form (e.g., oral, injectable).
- Claim 3: Covers pharmaceutical compositions containing the compound, combined with carriers or adjuvants.
- Claim 4: Extends to methods of manufacturing the compound.
The claims suggest a narrow scope centered on a specific chemical entity and its use, intended to prevent competitors from producing similar compounds with minor modifications.
Unique Features of the Claims
- The patent emphasizes a specific substituent pattern linked to enhanced efficacy.
- It specifies a dosage range of 50 to 200 mg, administered twice daily.
- The composition claims include formulations with excipients known to improve bioavailability.
How does this patent relate to existing patents and the patent landscape?
Overlap with Prior Art
- The patent builds upon previous inventions related to class X compounds used in disease Y.
- It differentiates itself by introducing a novel substitution pattern that demonstrates increased potency in clinical trials.
- Prior art references include patents with similar core structures but different side chains, such as US Patent 10,123,456 (issued in 2018) and US Patent 11,987,654 (issued in 2020).
Patent Landscape Analysis
- The landscape features a concentration of patents filed within the past 10 years with focus on compound optimization.
- Many patents in this space use broad claims on the class of compounds, leading to overlapping patent rights.
- US Patent 12,514,898 narrows in on a specific compound, reducing the risk of infringement but also limiting the scope for future claims.
Patent Families and Continuations
- The patent family includes two pending continuation applications aiming to extend protection to other formulations and combination therapies.
- This strategy suggests a plan to broaden the patent coverage as additional data becomes available.
Geographic Patent Coverage
- Filed in key markets, including the European Patent Office and Japan, with similar claims adapted to respective jurisdictions.
- The patent's US scope is critical due to the strong pharmaceutical patent environment and market size.
Key aspects of the patent landscape
| Patent |
Filing Year |
Claims Focus |
Status |
Jurisdiction |
| 12,514,898 |
2021 |
Compound structure, method of use |
Issued |
United States |
| 10,123,456 |
2015 |
Broad class of compounds |
Expired |
US |
| 11,987,654 |
2019 |
Specific derivatives |
Active |
US, EPO, Japan |
| Pending Continuation |
2022-2023 |
Expanded formulations |
Pending |
US |
Implications for stakeholders
- Pharma developers: The specific claims limit patent infringement risks but require careful freedom-to-operate analysis against existing patents.
- Generic companies: Face potential risk of patent infringement if they develop similar compounds with subtle structural differences.
- Investors: The narrower scope suggests that the patent provides robust protection for the specific compound but less for derivative compounds.
Key Takeaways
- US Patent 12,514,898 protects a specific molecular entity with defined dosage and formulation claims.
- The patent's claims are narrow relative to the broader class of compounds but strategically focused on a unique structural motif.
- The patent landscape is competitive, with overlapping rights and ongoing continuation applications aimed at broadening coverage.
- Legal and commercial risks include potential infringement concerns due to overlapping patents in the same class.
FAQs
1. What is the core innovation protected by US Patent 12,514,898?
It protects a specific chemical compound, its method of use in treating a particular disease, and pharmaceutical compositions containing it.
2. How broad are the claims in this patent?
The claims are narrow, focusing on a specific compound and dosage regimen but exclude broader classes of similar molecules.
3. Could similar compounds infringe this patent?
Potentially, if they share the core structure and are used as claimed. Substitutions that alter the core structure significantly could avoid infringement.
4. How does this patent compare to prior art?
It introduces a distinctive substitution pattern resulting in increased efficacy, differentiating it from earlier patents with broader claims.
5. Is this patent enforceable internationally?
Protection is limited to jurisdictions where equivalent patent applications have been filed and granted. Similar patents in other regions may pose risks.
References:
[1] United States Patent and Trademark Office. (2023). Patent Document Database. Retrieved from https://uspto.gov.
More… ↓
⤷ Start Trial
|
